{"id":3199,"date":"2024-06-10T11:22:33","date_gmt":"2024-06-10T15:22:33","guid":{"rendered":"https:\/\/cytel.agencyukdev.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/"},"modified":"2024-08-22T05:42:22","modified_gmt":"2024-08-22T09:42:22","slug":"how-to-overcome-common-challenges-to-patient-recruitment-projections","status":"publish","type":"perspectives","link":"https:\/\/cytel.agencyukdev.com\/fr\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/","title":{"rendered":"How to Overcome Common Challenges to Patient Recruitment Projections"},"content":{"rendered":"

For nearly ten years, suboptimal trial enrollment has been cited as a primary cause of clinical trial discontinuation. The Tufts Center for the Study of Drug Development released an impact report in 2013, in which it noted that nearly 37% of clinical trials miss enrollment targets [1]. A paper published in\u00a0JAMA\u00a0the following year revealed that enrollment was the reason most cited for clinical trial discontinuity [2]. A 2021 paper reviewing all discontinued clinical trials since 2000, revealed that enrollment forecasting remains the foremost reason for trial discontinuity, and suggests that this has cost the biotech and pharmaceutical industries approximately $40 billion USD (estimated conservatively*) [3].<\/p>\n

<\/p>\n

According to Cytel experts, more precise recruitment projections can be calculated through a model-based approach that accounts for\u00a0nonlinearity and\u00a0randomness\u00a0in the patient enrollment process. Intuitively, clinical operations specialists know that there will be site-level fluctuations. The same number of patients do not enroll every week, nor is there a straightforward way to account for how many will enroll. Yet, many conventional approaches to recruitment forecasting make exactly these assumptions.<\/p>\n

Sophisticated approaches might account for some nonlinearity – for example, it might be that as trials progress and recruitment efforts become more efficient, it is possible to scale the number of patients who enroll. Without statistical insight, though, it is very difficult to capture the idea of\u00a0randomness.<\/p>\n

A model-based approach advocated by Cytel experts enables a somewhat different line of reasoning. Instead of asking how long will it take to enroll 1000 patients, we can instead ask what is the probability that 1000 patients will be enrolled in fifteen months, twenty months or thirty months. We can then tackle nonlinearity by creating a model like the one below (Figure 3 in the attached whitepaper):<\/p>\n

\"\"<\/p>\n

 <\/p>\n

While this might appear to be a small adjustment in approach, consider that using site-level historical data, clinical operations teams can make such projections for each potential trial site. They can see, for example, that there is an 80% chance of hitting targets at one site and only 20% at another site, whether to focus recruitment initiatives in one place or another. It is then possible to build a cumulative enrollment curve that enables the prediction of conservative and risky targets for recruitment:<\/p>\n

\"\"<\/p>\n

 <\/p>\n

According to a Cytel whitepaper<\/a> on enrollment and patient recruitment, this can then lead to a number of new trial acceleration strategies and insights about relationships between key events.<\/p>\n

 <\/p>\n

\n

[1] Impact Report, Tufts Center for the Study of Drug Development,\u00a0 2013<\/p>\n

[2] Kasenda B., et al., Prevalence, characteristics and publication of discontinued randomized trials.\u00a0JAMA 2014<\/p>\n

[3] Vellinga, A., Lambe, K., O\u2019Connor, P.\u00a0et al.\u00a0What discontinued trials teach us about trial registration?.\u00a0BMC Res Notes\u00a014,\u00a047 (2021). https:\/\/doi.org\/10.1186\/s13104-020-05391-w<\/p>\n

*This assumes 163 discontinued trials, approximately $675,000 USD per trial and 37% of trials stopping due to patient recruitment issues.<\/p>\n

 <\/p>\n<\/div>\n","protected":false},"featured_media":3476,"parent":0,"template":"","meta":{"_acf_changed":false},"tags":[76],"by-topic":[435],"by-year":[72],"class_list":["post-3199","perspectives","type-perspectives","status-publish","has-post-thumbnail","hentry","tag-blog","by-topic-software","by-year-72"],"acf":[],"yoast_head":"\nHow to Overcome Common Challenges to Patient Recruitment Projections - Clinical Trial Software & Data Analysis | Cytel | Contact Us<\/title>\n<meta name=\"description\" content=\"A simulations-driven and model-based approach to tackle one of the key causes of clinical trial discontinuity: the inability to recruit enough patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to Overcome Common Challenges to Patient Recruitment Projections - Clinical Trial Software & Data Analysis | Cytel | Contact Us\" \/>\n<meta property=\"og:description\" content=\"A simulations-driven and model-based approach to tackle one of the key causes of clinical trial discontinuity: the inability to recruit enough patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Trial Software & Data Analysis | Cytel | Contact Us\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-22T09:42:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cytel.com\/wp-content\/uploads\/2024\/05\/Cytel_web_abstract-12.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1365\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cytel.com\\\/perspectives\\\/how-to-overcome-common-challenges-to-patient-recruitment-projections\\\/\",\"url\":\"https:\\\/\\\/www.cytel.com\\\/perspectives\\\/how-to-overcome-common-challenges-to-patient-recruitment-projections\\\/\",\"name\":\"How to Overcome Common Challenges to Patient Recruitment Projections - Clinical Trial Software & Data Analysis | Cytel | Contact Us\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cytel.com\\\/perspectives\\\/how-to-overcome-common-challenges-to-patient-recruitment-projections\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cytel.com\\\/perspectives\\\/how-to-overcome-common-challenges-to-patient-recruitment-projections\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Cytel_web_abstract-12.jpg\",\"datePublished\":\"2024-06-10T15:22:33+00:00\",\"dateModified\":\"2024-08-22T09:42:22+00:00\",\"description\":\"A simulations-driven and model-based approach to tackle one of the key causes of clinical trial discontinuity: the inability to recruit enough patients.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cytel.com\\\/perspectives\\\/how-to-overcome-common-challenges-to-patient-recruitment-projections\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cytel.com\\\/perspectives\\\/how-to-overcome-common-challenges-to-patient-recruitment-projections\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cytel.com\\\/perspectives\\\/how-to-overcome-common-challenges-to-patient-recruitment-projections\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Cytel_web_abstract-12.jpg\",\"contentUrl\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Cytel_web_abstract-12.jpg\",\"width\":2048,\"height\":1365},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cytel.com\\\/perspectives\\\/how-to-overcome-common-challenges-to-patient-recruitment-projections\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to Overcome Common Challenges to Patient Recruitment Projections\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/#website\",\"url\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/\",\"name\":\"Clinical Trial Software & Data Analysis | Cytel | Contact Us\",\"description\":\"Innovative Trial Design. Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How to Overcome Common Challenges to Patient Recruitment Projections - Clinical Trial Software & Data Analysis | Cytel | Contact Us","description":"A simulations-driven and model-based approach to tackle one of the key causes of clinical trial discontinuity: the inability to recruit enough patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/","og_locale":"fr_FR","og_type":"article","og_title":"How to Overcome Common Challenges to Patient Recruitment Projections - Clinical Trial Software & Data Analysis | Cytel | Contact Us","og_description":"A simulations-driven and model-based approach to tackle one of the key causes of clinical trial discontinuity: the inability to recruit enough patients.","og_url":"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/","og_site_name":"Clinical Trial Software & Data Analysis | Cytel | Contact Us","article_modified_time":"2024-08-22T09:42:22+00:00","og_image":[{"width":2048,"height":1365,"url":"https:\/\/www.cytel.com\/wp-content\/uploads\/2024\/05\/Cytel_web_abstract-12.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/","url":"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/","name":"How to Overcome Common Challenges to Patient Recruitment Projections - Clinical Trial Software & Data Analysis | Cytel | Contact Us","isPartOf":{"@id":"https:\/\/cytel.agencyukdev.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/#primaryimage"},"image":{"@id":"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/#primaryimage"},"thumbnailUrl":"https:\/\/cytel.agencyukdev.com\/wp-content\/uploads\/2024\/05\/Cytel_web_abstract-12.jpg","datePublished":"2024-06-10T15:22:33+00:00","dateModified":"2024-08-22T09:42:22+00:00","description":"A simulations-driven and model-based approach to tackle one of the key causes of clinical trial discontinuity: the inability to recruit enough patients.","breadcrumb":{"@id":"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/#primaryimage","url":"https:\/\/cytel.agencyukdev.com\/wp-content\/uploads\/2024\/05\/Cytel_web_abstract-12.jpg","contentUrl":"https:\/\/cytel.agencyukdev.com\/wp-content\/uploads\/2024\/05\/Cytel_web_abstract-12.jpg","width":2048,"height":1365},{"@type":"BreadcrumbList","@id":"https:\/\/www.cytel.com\/perspectives\/how-to-overcome-common-challenges-to-patient-recruitment-projections\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/cytel.agencyukdev.com\/"},{"@type":"ListItem","position":2,"name":"How to Overcome Common Challenges to Patient Recruitment Projections"}]},{"@type":"WebSite","@id":"https:\/\/cytel.agencyukdev.com\/#website","url":"https:\/\/cytel.agencyukdev.com\/","name":"Clinical Trial Software & Data Analysis | Cytel | Contact Us","description":"Innovative Trial Design. Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cytel.agencyukdev.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/perspectives\/3199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/perspectives"}],"about":[{"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/types\/perspectives"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/media\/3476"}],"wp:attachment":[{"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/media?parent=3199"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/tags?post=3199"},{"taxonomy":"by-topic","embeddable":true,"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/by-topic?post=3199"},{"taxonomy":"by-year","embeddable":true,"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/by-year?post=3199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}